Spontaneous apoptosis in chronic lymphocytic leukemia and its relationship to clinical and cell kinetic parameters
Open Access
- 15 December 2001
- Vol. 46 (6) , 329-335
- https://doi.org/10.1002/cyto.10031
Abstract
Chronic lymphocytic leukemia (CLL) presents considerable variability in clinical presentation as well as in its evolution. In contrast to the inhibition of apoptosis in vivo, spontaneous apoptosis after short‐term culture occurs. We studied the degree of this apoptosis in vitro, and its interactions with several clinical and laboratory parameters. Apoptosis was measured by the annexin V technique. Proliferation rate was evaluated by the AgNOR (nucleolar organizer regions) technique. There were inverse correlations between the percentage of annexin V‐positive cells and peripheral lymphocyte count (r = ‐ 0.49), Rai stage (r = ‐ 0.40), Binet stage (r = ‐ 0.50), TTM (total tumor mass score; r = ‐ 0.51), and percentage of cells with one AgNOR cluster (r = ‐ 0.45). Direct correlations were found with hemoglobin values ( r = 0.34) and platelet counts (r = 0.52). The number of CD8‐positive cells showed a correlation with peripheral lymphocyte count (r = 0.49). When this variable was held constant, a correlation was detected between CD8‐positive cells and staging (r = ‐0.47), TTM (r = ‐ 0.42), and platelet count (r = 0.67). CD4‐positive lymphocytes presented a correlation only with CD8‐positive lymphocytes. In a cluster analysis, it was possible to create three groups of patients with different apoptosis rates using the TTM and AgNOR values. We conclude that, with the progression of the disease, together with the increase of tumor mass and proliferation rate, there is a decrease in the suceptibility to apoptosis. Cytometry (Comm. Clin. Cytometry) 46:329–335, 2001.Keywords
This publication has 26 references indexed in Scilit:
- Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemiaBritish Journal of Haematology, 2001
- Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+T cells from B-CLL patients: impact on clonal B-cell apoptosisBritish Journal of Haematology, 2001
- Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cellsBlood, 2001
- Simultaneous Detection of BCL-2 Protein, Trisomy 12, Retinoblastoma and P53 Monoallelic Gene Deletions in B-Cell Chronic Lymphocytic Leukemia by Fluorescence in Situ Hybridization (FISH): Relation to Disease StatusLeukemia & Lymphoma, 2000
- Methods for analysing AgNORs.Journal of Clinical Pathology, 1999
- A low blood lymphocyte count is associated with an expansion of activated cytotoxic lymphocytes in patients with B‐cell chronic lymphocytic leukaemiaEuropean Journal of Haematology, 1997
- Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.Journal of Clinical Pathology, 1995
- Interleukin‐4 inhibits apoptotic cell death and loss of the bcl‐2 protein in B‐chronic lymphocytic leukaemia cells in vitroBritish Journal of Haematology, 1993
- Interpretation of the AgNOR Pattern in Hematologic CytologyActa Haematologica, 1993
- Total Tumour Mass Score (TTM): a New Parameter in Chronic Lymphocytic LeukaemiaBritish Journal of Haematology, 1981